Comparative analysis of Oct4 in different histological subtypes of esophageal squamous cell carcinomas in different clinical conditions

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 8, 2014, Pages 3519-3524

  Vaiphei, Kim ^a   Sinha, Saroj Kant ^a   Kochhar, Rakesh ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Cancer stem cell; Esophageal squamous cell carcinoma; Oct4

Indexed keywords

MESSENGER RNA; OCTAMER TRANSCRIPTION FACTOR 4; POU5F1 PROTEIN, HUMAN; TUMOR MARKER;

ADULT; AGED; CANCER STEM CELL; ESOPHAGUS; ESOPHAGUS TUMOR; FEMALE; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; SQUAMOUS CELL CARCINOMA; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASTIC STEM CELLS; OCTAMER TRANSCRIPTION FACTOR-3; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 84901985332     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.8.3519     Document Type: Article

References (48)

1. Atlasi Y, Mowla SJ, Ziaee SA, Bahrami AR (2006). OCT-4, an embryonic stem cell marker, is highly expressed in bladder cancer. Int J Cancer, 120, 1598-602.
2. Atlasi Y, Mowla SJ, Ziaee SA, Gokhale PJ, Andrews PW (2008). OCT4 spliced variants are differentially expressed in human pluripotent and nonpluripotent cells. Stem Cell, 26, 3068-74.
3. Bahl K, Saraya A, Sharma R (2012). Increased levels of circulating and tissue mRNAs of Oct-4, sox-2, Bmi-1 and nanog is escc patients: potential tool for minimally invasive cancer diagnosis. Biomarker Insights, 7, 27-37.
4. Campbell NP, Villaflor VM (2010). Neoadjuvant treatment of esophageal cancer. World J Gastroenterol, 16, 3793-803.
5. Cauffman G, Liebaers I, Van Steirteghem A, Van de Velde H (2006). POU5F1 isoforms show different expression patterns in human embryonic stem cells and preimplantation embryos. Stem Cells, 24, 2685-91.
6. Chen Z, Xu WR, Qian H, et al (2009). Oct4, a novel marker for human gastric cancer. J Surg Oncol, 99, 414-9.
7. Cheng L, Sung MT, Cossu-Rocca P, et al (2007). OCT4: biological functions and clinical applications as a marker of germ cell neoplasia. J Pathol, 211, 1-9.
8. Enzinger PC, Mayer RJ (2003). Esophageal cancer. N Engl J Med, 349, 2241-52.
9. Forte A, Schettino MT, Finicelli M, et al (2009). Expression pattern of stemness-related genes in human endometrial and endometriotic tissue. Mol Med, 15, 392-401.
10. Gao JX (2008). Cancer stem cells: the lessons from pre-cancerous stem cells. J Cell Mol Med, 12, 67-96.
11. Ghisolfi L, Keates AC, Hu X, Lee D-k, Li CJ (2012). Ionizing radiation induces stemness in cancer cells. PLoS, 7, 43628.
12. He W, Li K, Wang F, Qin YR, Fan QX (2012). Expression of OCT4 in human esophageal squamous cell carcinoma is significantly associated with poorer prognosis. World J Gastroenterol, 18, 712-9.
13. He W, Li K, Wang F, Qin YR, Fan QX (2012). Expression of OCT4 in human esophageal squamous cell carcinoma is significantly associated with poorer prognosis. World J Gastroenterol, 18, 712-9.
14. Hochedlinger K, Plath K (2009). Epigenetic reprogramming and induced pluripotency. Development, 136, 509.
15. Hochedlinger K, Yamada Y, Beard C, Jaenisch R (2005). Ectopic expression of Oct-4 blocks progenitor-cell differentiation and causes dysplasia in epithelial tissues. Cell, 121, 465-77.
16. Hu T, Liu S, Breiter DR, et al (2008). Octamer 4 small interfering RNA results in cancer stem cell-like cell apoptosis. Cancer Res, 68, 6533-40.
17. Huang CP, Tsai MF, Chang TH, et al (2013). ALDH-positive lung cancer stem cells confer resistance to epidermal growth factor receptor tyrosine kinase inhibitors. Cancer Lett, 328, 144-51.
18. Huang D, Gao Q, Guo L, et al (2009). Isolation and identification of cancer stem-like cells in esophageal carcinoma cell lines. Stem Cells, 18, 465-73.
19. ICMR (2002). National cancer registry programme, 1981-2001, an overview. Indian council of medical research, New Delhi.
20. Ilett EJ, Prestwich RJ, Melcher AA (2010).The evolving role of dendritic cells in cancer therapy. Expert Opin Biol Ther, 10, 369.
21. Islam M, Sharma S, Teknos TN (2014). RhoC regulates cancer stem cells in head and neck squamous cell carcinoma by overexpressing IL-6 and phosphorylation of STAT3. PLoS One, 9, e88527.
22. Jones T, Ulbright T, Eble J, Baldridge L, Cheng L (2004). OCT4 staining in testicular tumors: a sensitive and specific marker for seminoma and embryonal carcinoma. Am J Surg Pathol, 28, 935-40.
23. Katona TM, Billings SD, Montironi R, Lopez-Beltran A, Cheng L (2007). Expression of OCT4 transcription factor in cutaneous neoplasia. Appl Immunohistochem Mol Morphol, 15, 359-62.
24. Kim MC, Cui FJ, Kim Y (2013). Hydrogen peroxide promotes epithelial to mesenchymal transition and stemness in human malignant mesothelioma cells. Asian Pac J Cancer Prev, 14, 3625-30.
25. Koukourakis MI, Giatromanolaki A, Tsakmaki V, Danielidis V, Sivridis E (2012). Cancer stem cell phenotype relates to radio-chemotherapy outcome in locally advanced squamous cell head-neck cancer. Br J Cancer, 106, 846-53.
26. Lee J, Kim HK, Rho JY, Han YM, Kim J (2006). The human OCT-4 isoforms differ in their ability to confer self-renewal. J Biol Chem, 281, 33554-65.
27. Li MH, Li P, Li PJ (1980). Recent progress in research on esophageal cancer in China. Adv Cancer Res, 33,173-249.
28. Li X, Wang J, Xu Z, et al (2012). Expression of Sox2 and Oct4 and their clinical significance in human non-small-cell lung cancer. Int J Mol Sci, 13, 7663-75.
29. Matthai C, Horvat R, Noe M, et al (2006). Oct-4 expression in human endometrium. Mol Hum Reprod, 12, 7-10.
30. Monk M, Holding C (2001). Human embryonic genes re-expressed in cancer cells. Oncogene, 20, 8085-91.
31. Nichols J, Zevnik B, Anastassiadis K, et al (1998). Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell1, 95, 379-91.
32. Niwa H, Miyazaki J, Smith AG (2000). Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat Genet, 24, 372-6.
33. Parkin DM, Bray F, Ferlay J, Pisani P (2001). Estimates of the world cancer burden: globocan 2000. Int J Cancer, 94, 153-6.
34. Parkin DM, Bray F, Ferlay J, Pisani P (2005). Global cancer statistics, 2002. CA Cancer J Clin, 55, 74-108.
35. Rosenthal DT, Zhang J, Bao L, et al (2012). RhoC impacts the metastatic potential and abundance of breast cancer stem cells. PLoS One, 7, e40979.
36. Huang CP, Tsai MF, Chang TH, et al (2013). ALDH positive lung cancer stem cells confer resistance to epidermal growth factor receptor tyrosine kinase inhibitors. Cancer Lett, 328, 144-51.
37. Sanada Y, Yoshida K, Ohara M, et al (2006). Histopathologic evaluation of stepwise progression of pancreatic carcinoma with immunohistochemical analysis of gastric epithelial transcription factor SOX2: comparison of expression patterns between invasive components and cancerous or non-neoplastic intraductal components. Pancreas, 32, 164-70.
38. Tai MH, Chang CC, Olson KL, Trosko JE (2005). Oct4 expression in adult human stem cells: evidence in support of the stem cell theory of carcinogenesis. Carcinogenesis, 26, 495-502.
39. Wang QI, Hei W, Lu C, et al (2009). Oct3/4 and Sox2 are significantly associated with an unfavorable clinical outcome in human esophageal squamous cell carcinoma. Anticancer Res, 29, 1233-42.
40. Warren L, Manos PD, Ahfeldt T, et al (2010). Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell, 7, 618.
41. Warthemann R, Eildermann K, Debowski K, Behr R (2012). False-positive antibody signals for the pluripotency factor OCT4A (POU5F1) in testis-derived cells may lead to erroneous data and misinterpretations. Mol Hum Reprod, 18, 605-12.
42. Wicha MS (2014). Targeting self-renewal, an Achilles' heel of cancer stem cells. Nat Med, 20, 14-5.
43. Xi Z, Guang-Rong H, Pin H (2011). Over-expression of Oct4 in human esophageal squamous cell carcinoma. Mol Cells, 32, 39-45.
44. Zangrossi S, Marabese M, Broggini M, et al (2007). Oct-4 expression in adult human differentiated cells challenges its role as a pure stem cell marker. Stem Cells, 25, 1675-80.
45. Zhang AM, Fan Y, Yao Q, et al (2012). Identification of a cancer stem-like population in the Lewis lung cancer cell line. Asian Pac J Cancer Prev, 13, 761-6.
46. Zhang X, Komaki R, Wang L, Fang B, Chang JY (2008). Treatment of radioresistant stem-like esophageal cancer cells by an apoptotic gene-armed, telomerase-specific oncolytic adenovirus. Clin Cancer Res, 14, 2813-23.
47. Zhou GX, Li XY, Zhang Q, et al (2013). Effects of the hippo signaling pathway in human gastric cancer. Asian Pac J Cancer Prev, 14, 5199-205.
48. Zhou H, Ding S (2010). Evolution of induced pluripotent stem cell technology. Curr Opin Hematol, 17, 276.